ANI Pharmaceuticals Inc.
ANIP | NASDAQ
$77.17
-$1.68 (-2.13%)
Sep 22, 2026, 1:59 PM ET · Market open
Market Data
Market Cap $1.79B
Enterprise Value $1.76B
Beta 0.45
Average Volume 356.84K
Shares Outstanding (Diluted) 21.92M
Shares Change YoY 7.91%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US00182C1036
Price Performance
Price Change 1M 4.7%
Price Change 3M -4.9%
Price Change 6M 6.5%
Price Change YTD 0.5%
Price Change 1Y -17.8%
Price Change 3Y 34.7%
Price Change 5Y 146.8%
1M CAGR (ann.) 0.8%
1Y CAGR (ann.) -19.1%
5Y CAGR (ann.) 22.8%
All-Time CAGR 1.2%
Valuation
PE Ratio 17.03
Forward PE 7.70
PEG Ratio 0.01
Forward PEG 1.27
PS Ratio 1.83
Forward PS 1.50
PB Ratio 3.00
P/FCF Ratio 11.24
P/Adj. FCF Ratio 15.14
P/OCF Ratio 8.81
EV/Sales 1.80
EV/EBIT 13.63
EV/EBITDA 7.09
EV/FCF 11.06
Earnings Yield 5.9%
FCF Yield 8.9%
Adj. FCF Yield 6.6%
Financial Health
Net Cash $29.87M
Total Debt $330.34M
Cash & Short-Term Investments $360.21M
Total Assets $1.49B
Current Ratio 2.91
Quick Ratio 2.41
Debt / Equity Ratio 0.55
Debt / EBITDA 1.33
Debt / FCF 2.07
OCF / Debt 0.57
Interest Coverage 5.47
Altman Z-Score 2.60
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 65.2%
Operating Profit Margin 15.3%
EBITDA Margin 26.1%
Net Profit Margin 10.8%
FCF Margin 16.3%
Adj. FCF Margin 12.1%
SBC / Revenue 4.2%
SBC Impact (per share) -25.8%
Returns
Return on Assets 7.1%
Return on Equity 19.2%
Return on Invested Capital 9.3%
Return on Capital Employed 12.4%
Return on Tangible Assets 10.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 34.6%
Revenue CAGR 5Y 35.6%
Revenue CAGR 10Y 27.0%
EPS CAGR 3Y 100.2%
EPS CAGR 5Y 2022.1%
EPS CAGR 10Y 18.3%
FCF CAGR 3Y 102.7%
FCF CAGR 5Y 78.3%
FCF CAGR 10Y 61.1%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 10
EPS Growth Next 3Y 39.4%
Revenue Growth Next 3Y 12.7%
Earnings Date Nov 5, 2026
EPS Estimate (next Q) $2.12
EPS Growth Est (next Q) 3.9%
Revenue Est (next Q) $280.06M
Revenue Growth Est (next Q) 22.9%
Fair Value Estimates
Graham Number $54.23
Graham Upside -31.2%
Lynch Fair Value $115.75
Lynch Upside 46.8%
Price Target $104.33
Price Target Upside 32.3%
Cash Flow
Operating Cash Flow $189.47M
Free Cash Flow $159.44M
Adj. Free Cash Flow $118.39M
FCF Per Share $7.54
OCF Per Share $8.95
OCF/S Ratio 19.4%
Income Statement
Revenue $978.38M
Gross Profit $472.31M
Operating Income $150.17M
EBITDA $248.56M
Net Income $105.83M
EPS (Diluted) $4.63
Revenue / Employee $1.01M
Profit / Employee $109.1K
Employees 970
Add to Watchlist
Select watchlists to add or remove ANIP